✦ LIBER ✦

Front-line High-Dose Chemotherapy with Rituximab Showed Excellent Long-Term Survival in Adults with Aggressive Large B-Cell Lymphoma: Final Results of a Phase II GOELAMS Study

✍ Scribed by Marie-Sarah Dilhuydy; Thierry Lamy; Charles Foussard; Remy Gressin; Philippe Casassus; Eric Deconninck; Christine Le Maignan; Diane Damotte; Noel Milpied

Book ID: 116281721
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 190 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.12.530

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with autologous s

High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group

✍ Colombat, Ph; Lemevel, A; Bertrand, P; Delwail, V; Rachieru, P; Brion, A; Bertho 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Phase II study of a high-dose ifosfamide

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

✍ van Besien, K; Rodriguez, A; Tomany, S; Younes, A; Donato, M; Sarris, A; Giralt, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB